|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| A61K 38/13 | |||
| A61K 39/395 | |||
| A61K 45/06 | |||
| A61P 37/06 |
| (11) | Patento numeris | 2683406 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12758099.1 |
| Europos patento paraiškos padavimo data | 2012-03-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-01-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-05-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/028782 |
| Data | 2012-03-12 |
| (87) | Numeris | WO 2012/125569 |
| Data | 2012-09-20 |
| (30) | Numeris | Data | Šalis |
| 201161451870 P | 2011-03-11 | US |
| (72) |
REIMANN, Keith, A., US
WANG, Rijian, US
LARSEN, Christian, P., US
|
| (73) |
Beth Israel Deaconess Medical Center, Inc.,
330 Brookline Avenue, Boston, MA 02215,
US
Emory University, Office of Technology Transfer 1599 Clifton Rd. NE, Atlanta, GA 30322, US |
| (54) | ANTI-CD40 ANTIBODIES AND USES THEREOF |
| ANTI-CD40 ANTIBODIES AND USES THEREOF |